Exact Mass: 267.0644

Exact Mass Matches: 267.0644

Found 100 metabolites which its exact mass value is equals to given mass value 267.0644, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Sulfisoxazole

4-amino-N-(dimethyl-1,2-oxazol-5-yl)benzene-1-sulfonamide

C11H13N3O3S (267.0678)


Sulfisoxazole is only found in individuals that have used or taken this drug. It is a short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms. [PubChem]Sulfisoxazole is a competitive inhibitor of the enzyme dihydropteroate synthetase. It inhibits bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3072; ORIGINAL_PRECURSOR_SCAN_NO 3068 CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6520; ORIGINAL_PRECURSOR_SCAN_NO 6519 CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3077; ORIGINAL_PRECURSOR_SCAN_NO 3073 CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6493; ORIGINAL_PRECURSOR_SCAN_NO 6491 CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6549; ORIGINAL_PRECURSOR_SCAN_NO 6547 CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3096; ORIGINAL_PRECURSOR_SCAN_NO 3094 CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3126; ORIGINAL_PRECURSOR_SCAN_NO 3125 CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6542; ORIGINAL_PRECURSOR_SCAN_NO 6539 CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6522; ORIGINAL_PRECURSOR_SCAN_NO 6521 CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6555; ORIGINAL_PRECURSOR_SCAN_NO 6553 CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3083; ORIGINAL_PRECURSOR_SCAN_NO 3080 CONFIDENCE standard compound; INTERNAL_ID 636; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3067; ORIGINAL_PRECURSOR_SCAN_NO 3065 J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EB - Short-acting sulfonamides S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AB - Sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides CONFIDENCE standard compound; INTERNAL_ID 1013 Sulfisoxazole (Sulfafurazole) is an orally active endothelin receptor antagonist with IC50 values of 0.60 μM and 22 μM against endothelin receptor A and endothelin receptor B, respectively. Sulfisoxazole is a sulfonamide antibacterial agent with an oxazole substituent. Sulfisoxazole inhibits breast cancer exosome release by targeting endothelin receptor A[1][2].

   

OXYCARBOXIN

1,4-Oxathiin-3-carboxamide,5,6-dihydro-2-methyl-N-phenyl-, 4,4-dioxide

C12H13NO4S (267.0565)


A substituted aniline that is aniline in which one of the hydrogens attached to the nitrogen atom by a (2-methyl-4,4-dioxido-5,6-dihydro-1,4-oxathiin-3-yl)carbonyl group. CONFIDENCE standard compound; INTERNAL_ID 1027; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7124; ORIGINAL_PRECURSOR_SCAN_NO 7121 CONFIDENCE standard compound; INTERNAL_ID 1027; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3210; ORIGINAL_PRECURSOR_SCAN_NO 3208 CONFIDENCE standard compound; INTERNAL_ID 1027; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3197; ORIGINAL_PRECURSOR_SCAN_NO 3195 CONFIDENCE standard compound; INTERNAL_ID 1027; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7117; ORIGINAL_PRECURSOR_SCAN_NO 7114 CONFIDENCE standard compound; INTERNAL_ID 1027; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3208; ORIGINAL_PRECURSOR_SCAN_NO 3207 CONFIDENCE standard compound; INTERNAL_ID 1027; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7096; ORIGINAL_PRECURSOR_SCAN_NO 7091 CONFIDENCE standard compound; INTERNAL_ID 1027; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3211; ORIGINAL_PRECURSOR_SCAN_NO 3209 CONFIDENCE standard compound; INTERNAL_ID 1027; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3204; ORIGINAL_PRECURSOR_SCAN_NO 3202 CONFIDENCE standard compound; INTERNAL_ID 1027; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3196; ORIGINAL_PRECURSOR_SCAN_NO 3194 CONFIDENCE standard compound; INTERNAL_ID 1027; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7129; ORIGINAL_PRECURSOR_SCAN_NO 7127

   

Chlornaphazine

N,N-BIS(2-CHLOROETHYL)-2-NAPHTHYLAMINE

C14H15Cl2N (267.0581)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

2-Amino-4-oxo-6-(1',2'-dioxoprolyl)-7,8-dihydroxypteridine

1-(2-amino-7,8-dihydroxy-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)propane-1,2-dione

C9H9N5O5 (267.0604)


This compound It is a byproduct of 6-pyruvoyltetrahydropterin synthase (EC 4.2.3.12), and associated with 6-Pyruvoyltetrahydropterin synthase deficiency (an autosomal recessive disorder that causes malignant hyperphenylalaninemia due to tetrahydrobiopterin deficiency). (Wikipedia). This compound It is a byproduct of 6-pyruvoyltetrahydropterin synthase (EC 4.2.3.12), and associated with 6-Pyruvoyltetrahydropterin synthase deficiency (an autosomal recessive disorder that causes malignant hyperphenylalaninemia due to tetrahydrobiopterin deficiency). [HMDB]

   

Sulfamoxole

4-amino-N-(dimethyl-1,3-oxazol-2-yl)benzene-1-sulfonamide

C11H13N3O3S (267.0678)


Sulfamoxole is only found in individuals that have used or taken this drug. It is a sulfonamide antibacterial. Sulfamoxole is a competitive inhibitor of the bacterial enzyme dihydropteroate synthetase. This enzyme is needed for the proper processing of para-aminobenzoic acid (PABA) which is essential for folic acid synthesis. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EC - Intermediate-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

   

Sulfatroxazole

4-Amino-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzene-1-sulphonamide

C11H13N3O3S (267.0678)


   

ICM 0201

(3S,10aR)-3,4a-Dihydroxy-2,3,4,4a-tetrahydro-2H-pyrano[3,2-b]benzo[e] morpholine-9-carboxylic acid

C12H13NO6 (267.0743)


   
   

AKOS005919557

AKOS005919557

C12H13NO6 (267.0743)


   
   

L-erythro-N-benzoyl-3-hydroxy-glutamic acid|L-erythro-N-Benzoyl-3-hydroxy-glutaminsaeure

L-erythro-N-benzoyl-3-hydroxy-glutamic acid|L-erythro-N-Benzoyl-3-hydroxy-glutaminsaeure

C12H13NO6 (267.0743)


   

3-(2-amino-4,6-dioxo-3,4,5,6-tetrahydro-pteridin-7-yl)-2-hydroxy-propionic acid|Ekapterin

3-(2-amino-4,6-dioxo-3,4,5,6-tetrahydro-pteridin-7-yl)-2-hydroxy-propionic acid|Ekapterin

C9H9N5O5 (267.0604)


   

sulfamoxol

4-amino-N-(dimethyl-1,3-oxazol-2-yl)benzene-1-sulfonamide

C11H13N3O3S (267.0678)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EC - Intermediate-acting sulfonamides A sulfonamide-based antibacterial agent where 4-aminobenzenesulfonic acid and 4,5-dimethyl-1,3-oxazol-2-amine have combined to form the sulfonamide bond. C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides CONFIDENCE standard compound; INTERNAL_ID 8; HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) Flow Injection; CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu); Flow Injection CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) CONFIDENCE standard compound; INTERNAL_ID 1019

   

sulfisoxazole

sulfisoxazole

C11H13N3O3S (267.0678)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EB - Short-acting sulfonamides S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AB - Sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides Sulfisoxazole (Sulfafurazole) is an orally active endothelin receptor antagonist with IC50 values of 0.60 μM and 22 μM against endothelin receptor A and endothelin receptor B, respectively. Sulfisoxazole is a sulfonamide antibacterial agent with an oxazole substituent. Sulfisoxazole inhibits breast cancer exosome release by targeting endothelin receptor A[1][2].

   

2-Amino-4-oxo-6-(1,2-dioxoprolyl)-7,8-dihydroxypteridine

2-Amino-4-oxo-6-(1,2-dioxoprolyl)-7,8-dihydroxypteridine

C9H9N5O5 (267.0604)


   

3,3a,4,5,6,7-hexahydro-3-hydroxy-2-thiocarbamoyl-3-trifluoromethyl-2h-indazole

3,3a,4,5,6,7-hexahydro-3-hydroxy-2-thiocarbamoyl-3-trifluoromethyl-2h-indazole

C9H12F3N3OS (267.0653)


   

3-(3-nitrophenyl)imidazo[1,5-a]pyridine-1-carbaldehyde

3-(3-nitrophenyl)imidazo[1,5-a]pyridine-1-carbaldehyde

C14H9N3O3 (267.0644)


   

1-(2-chlorobenzoyl)piperidine-4-carboxylic acid

1-(2-chlorobenzoyl)piperidine-4-carboxylic acid

C13H14ClNO3 (267.0662)


   

5-Chloro-3,6-diphenyl-1,2,4-triazine

5-Chloro-3,6-diphenyl-1,2,4-triazine

C15H10ClN3 (267.0563)


   

p-Bromo-N-cyclohexyl-N-metylaniline

p-Bromo-N-cyclohexyl-N-metylaniline

C13H18BrN (267.0623)


   

6-(Dimethylamino)-4-hydroxy-2-naphthalenesulfonic acid

6-(Dimethylamino)-4-hydroxy-2-naphthalenesulfonic acid

C12H13NO4S (267.0565)


   

4-(2-fluorophenoxy)pyridine-2-carboximidamide,hydrochloride

4-(2-fluorophenoxy)pyridine-2-carboximidamide,hydrochloride

C12H11ClFN3O (267.0575)


   

4-(4-fluorophenoxy)pyridine-2-carboximidamide,hydrochloride

4-(4-fluorophenoxy)pyridine-2-carboximidamide,hydrochloride

C12H11ClFN3O (267.0575)


   

4-(3-fluorophenoxy)pyridine-2-carboximidamide,hydrochloride

4-(3-fluorophenoxy)pyridine-2-carboximidamide,hydrochloride

C12H11ClFN3O (267.0575)


   

2-[(4-BROMOPHENYL)METHYL]HEXAHYDRO-1H-AZEPINE

2-[(4-BROMOPHENYL)METHYL]HEXAHYDRO-1H-AZEPINE

C13H18BrN (267.0623)


   

2-(4-NITROPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXALDEHYDE

2-(4-NITROPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXALDEHYDE

C14H9N3O3 (267.0644)


   

2-(4-fluoro-phenyl)-quinoline-4-carboxylic acid

2-(4-fluoro-phenyl)-quinoline-4-carboxylic acid

C16H10FNO2 (267.0696)


   

4-CHLORO-9-METHYL-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE

4-CHLORO-9-METHYL-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE

C14H15Cl2N (267.0581)


   

4-[4-(chloromethyl)piperidin-1-yl]thieno[3,2-d]pyrimidine

4-[4-(chloromethyl)piperidin-1-yl]thieno[3,2-d]pyrimidine

C12H14ClN3S (267.0597)


   

DIMETHYL (4-NITROBENZYL)MALONATE

DIMETHYL (4-NITROBENZYL)MALONATE

C12H13NO6 (267.0743)


   

2-[carboxymethyl(phenylmethoxycarbonyl)amino]acetic acid

2-[carboxymethyl(phenylmethoxycarbonyl)amino]acetic acid

C12H13NO6 (267.0743)


   

1,2,4-Triazine,3-chloro-5,6-diphenyl-

1,2,4-Triazine,3-chloro-5,6-diphenyl-

C15H10ClN3 (267.0563)


   

1-(3-Chlorobenzoyl)piperidine-4-carboxylic acid

1-(3-Chlorobenzoyl)piperidine-4-carboxylic acid

C13H14ClNO3 (267.0662)


   

1-(4-CHLOROBENZYL)-1H-PYRAZOL-5-AMINEHYDROCHLORIDE

1-(4-CHLOROBENZYL)-1H-PYRAZOL-5-AMINEHYDROCHLORIDE

C13H14ClNO3 (267.0662)


   

2-BENZO[1,3]DIOXOL-5-YL-IMIDAZO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE

2-BENZO[1,3]DIOXOL-5-YL-IMIDAZO[1,2-A]PYRIMIDINE-3-CARBALDEHYDE

C14H9N3O3 (267.0644)


   

1-(4-CHLORO-3-NITROPHENYL)PROPAN-1-ONE

1-(4-CHLORO-3-NITROPHENYL)PROPAN-1-ONE

C13H14ClNO3 (267.0662)


   

2-Naphthalenesulfonicacid, 5-amino-6-ethoxy-

2-Naphthalenesulfonicacid, 5-amino-6-ethoxy-

C12H13NO4S (267.0565)


   

4-[(3,5-Dimethyl-4-isoxazolyl)methoxy]-2,6-difluorobenzenemethanol

4-[(3,5-Dimethyl-4-isoxazolyl)methoxy]-2,6-difluorobenzenemethanol

C13H11F2NO3 (267.0707)


   

1-[3-(4-Bromophenyl)propyl]pyrrolidine

1-[3-(4-Bromophenyl)propyl]pyrrolidine

C13H18BrN (267.0623)


   

Zonisamide N,N-Dimethylformimidamide

Zonisamide N,N-Dimethylformimidamide

C11H13N3O3S (267.0678)


   

8-fluoro-2-phenylquinoline-4-carboxylic acid

8-fluoro-2-phenylquinoline-4-carboxylic acid

C16H10FNO2 (267.0696)


   

8-oxo-7-phenylpyrido[2,3-d]pyridazine-5-carboxylic acid

8-oxo-7-phenylpyrido[2,3-d]pyridazine-5-carboxylic acid

C14H9N3O3 (267.0644)


   

4-(3,4-DIFLUOROPHENYL)-1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-3-PYRIDINECARBOXYLIC ACID

4-(3,4-DIFLUOROPHENYL)-1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-3-PYRIDINECARBOXYLIC ACID

C13H11F2NO3 (267.0707)


   

2-(2-fluorophenyl)quinoline-4-carboxylic acid

2-(2-fluorophenyl)quinoline-4-carboxylic acid

C16H10FNO2 (267.0696)


   

6-chloro-2-(1,4-diazepan-1-yl)-1,3-benzothiazole

6-chloro-2-(1,4-diazepan-1-yl)-1,3-benzothiazole

C12H14ClN3S (267.0597)


   

dimethyl 2-(4-methoxycarbonylpyridin-3-yl)propanedioate

dimethyl 2-(4-methoxycarbonylpyridin-3-yl)propanedioate

C12H13NO6 (267.0743)


   

2-(3-nitrophenyl)-4-pyridin-2-yl-1,3-oxazole

2-(3-nitrophenyl)-4-pyridin-2-yl-1,3-oxazole

C14H9N3O3 (267.0644)


   

N-Phenylaniline sulfate (1:1)

N-Phenylaniline sulfate (1:1)

C12H13NO4S (267.0565)


   

4-(Chloromethyl)-2-(3,4-dimethoxyphenyl)-5-methyl-1,3-oxazole

4-(Chloromethyl)-2-(3,4-dimethoxyphenyl)-5-methyl-1,3-oxazole

C13H14ClNO3 (267.0662)


   

4-(2,4-DIFLUOROPHENYL)-1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-3-PYRIDINECARBOXYLIC ACID

4-(2,4-DIFLUOROPHENYL)-1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-3-PYRIDINECARBOXYLIC ACID

C13H11F2NO3 (267.0707)


   

2-(4-CHLOROPHENYL)-2-PHENYLETHYLAMINE HYDROCHLORIDE

2-(4-CHLOROPHENYL)-2-PHENYLETHYLAMINE HYDROCHLORIDE

C14H15Cl2N (267.0581)


   

2-Chloro-3-(3-chloropropyl)-5,7-dimethylquinoline

2-Chloro-3-(3-chloropropyl)-5,7-dimethylquinoline

C14H15Cl2N (267.0581)


   

2-Chloro-3-(3-chloropropyl)-5,8-dimethylquinoline

2-Chloro-3-(3-chloropropyl)-5,8-dimethylquinoline

C14H15Cl2N (267.0581)


   

2-Chloro-3-(3-chloropropyl)-6,8-dimethylquinoline

2-Chloro-3-(3-chloropropyl)-6,8-dimethylquinoline

C14H15Cl2N (267.0581)


   

2-Chloro-3-(3-chloropropyl)-6-ethylquinoline

2-Chloro-3-(3-chloropropyl)-6-ethylquinoline

C14H15Cl2N (267.0581)


   

5-(3-Chlorophenyl)-4-isobutyl-4H-1,2,4-triazole-3-thiol

5-(3-Chlorophenyl)-4-isobutyl-4H-1,2,4-triazole-3-thiol

C12H14ClN3S (267.0597)


   

7-trifluoromethoxy-2,3,4,5-tetrahydro-1h-benzo[b]azepine hydrochloride

7-trifluoromethoxy-2,3,4,5-tetrahydro-1h-benzo[b]azepine hydrochloride

C11H13ClF3NO (267.0638)


   

2-Chloro-3-(3-chloropropyl)-6,7-dimethylquinoline

2-Chloro-3-(3-chloropropyl)-6,7-dimethylquinoline

C14H15Cl2N (267.0581)


   

3-(Phenylthiomethyl)benzoylacetonitrile

3-(Phenylthiomethyl)benzoylacetonitrile

C16H13NOS (267.0718)


   

Diethyl 5-nitroisophthalate

Diethyl 5-nitroisophthalate

C12H13NO6 (267.0743)


   

4-([(2-FURYLMETHYL)AMINO]METHYL)BENZOIC ACID HYDROCHLORIDE

4-([(2-FURYLMETHYL)AMINO]METHYL)BENZOIC ACID HYDROCHLORIDE

C13H14ClNO3 (267.0662)


   

Morpholine,2-[3-(trifluoromethyl)phenyl]-, hydrochloride (1:1)

Morpholine,2-[3-(trifluoromethyl)phenyl]-, hydrochloride (1:1)

C11H13ClF3NO (267.0638)


   

Sulfatroxazole

4-Amino-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide

C11H13N3O3S (267.0678)


C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

   
   

1-(2-ethyl-4-hydroxy-1,1-dioxo-1λ6,2-benzothiazin-3-yl)ethanone

1-(2-ethyl-4-hydroxy-1,1-dioxo-1λ6,2-benzothiazin-3-yl)ethanone

C12H13NO4S (267.0565)


   

N-[(Benzyloxy)carbonyl]aspartic acid

N-[(Benzyloxy)carbonyl]aspartic acid

C12H13NO6 (267.0743)


   

6'-Chloro-3,2:5,3'-terpyridine

6"-Chloro-3,2:5,3"-terpyridine

C15H10ClN3 (267.0563)


   
   

4-Chloro-2,2:6,2-terpyridine

4-Chloro-2,2:6,2-terpyridine

C15H10ClN3 (267.0563)


   

2-Chloro-4,6-diphenyl-1,3,5-triazine

2-Chloro-4,6-diphenyl-1,3,5-triazine

C15H10ClN3 (267.0563)


   

3-[2-(trifluoromethyl)phenoxy]pyrrolidine,hydrochloride

3-[2-(trifluoromethyl)phenoxy]pyrrolidine,hydrochloride

C11H13ClF3NO (267.0638)


   

Aladorian

Aladorian

C12H13NO4S (267.0565)


C78274 - Agent Affecting Cardiovascular System

   

2-(3-Nitrophenyl)-5-phenyl-1,3,4-oxadiazole

2-(3-Nitrophenyl)-5-phenyl-1,3,4-oxadiazole

C14H9N3O3 (267.0644)


   

9-Chloro-6-methylindolo[3,2-b]quinoxaline

9-Chloro-6-methylindolo[3,2-b]quinoxaline

C15H10ClN3 (267.0563)


   

Methyl 2-(chloroacetyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate

Methyl 2-(chloroacetyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate

C13H14ClNO3 (267.0662)


   

3-Phenyl-5-[(phenylthio)methyl]isoxazole

3-Phenyl-5-[(phenylthio)methyl]isoxazole

C16H13NOS (267.0718)


   

beta-Chloro-alpha-phenylbenzeneethanamine hydrochloride

beta-Chloro-alpha-phenylbenzeneethanamine hydrochloride

C14H15Cl2N (267.0581)


   

Methyl(2-acetoxy-2-(2-carboxy-4-amino-phenyl))acetate

Methyl(2-acetoxy-2-(2-carboxy-4-amino-phenyl))acetate

C12H13NO6 (267.0743)


   

2-O-(alpha-D-glucopyranosyl)-D-glycerate

2-O-(alpha-D-glucopyranosyl)-D-glycerate

C9H15O9- (267.0716)


   

3-deoxy-D-glycero-beta-D-galacto-nonulosonate

3-deoxy-D-glycero-beta-D-galacto-nonulosonate

C9H15O9- (267.0716)


A carbohydrate acid derivative anion obtained by deprotonation of the carboxy group of 3-deoxy-D-glycero-beta-D-galacto-nonulosonic acid

   

2-(alpha-D-mannosyl)-D-glycerate

2-(alpha-D-mannosyl)-D-glycerate

C9H15O9- (267.0716)


Conjugate base of 2-(alpha-D-mannosyl)-D-glyceric acid

   

N-(4-hydroxybenzoyl)-L-glutamic acid

N-(4-hydroxybenzoyl)-L-glutamic acid

C12H13NO6 (267.0743)


   

3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonate

3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonate

C9H15O9- (267.0716)


   

3-deoxy-D-glycero-alpha-D-galacto-nonulosonate

3-deoxy-D-glycero-alpha-D-galacto-nonulosonate

C9H15O9- (267.0716)


   

Formononetin(1-)

Formononetin(1-)

C16H11O4- (267.0657)


A flavonoid oxoanion that is the conjugate base of formononetin, obtained by deprotonation of the 7-hydroxy group. Major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

N-(1-naphthalenylmethyl)-2-thiophenecarboxamide

N-(1-naphthalenylmethyl)-2-thiophenecarboxamide

C16H13NOS (267.0718)


   

8-Methoxyflavone-7-olate

8-Methoxyflavone-7-olate

C16H11O4- (267.0657)


   

n-Butanal, o-[(pentafluorophenyl)methyl]oxime

n-Butanal, o-[(pentafluorophenyl)methyl]oxime

C11H10F5NO (267.0683)


   

2-Butanone O-[(pentafluorophenyl)methyl]oxime

2-Butanone O-[(pentafluorophenyl)methyl]oxime

C11H10F5NO (267.0683)


   

Aminooxo(dioxoprolyl)dihydroxypteridine

Aminooxo(dioxoprolyl)dihydroxypteridine

C9H9N5O5 (267.0604)


   

2-[(4-hydroxyphenyl)formamido]pentanedioic acid

2-[(4-hydroxyphenyl)formamido]pentanedioic acid

C12H13NO6 (267.0743)


   

2-methyl-4,4-dioxo-n-phenyl-5,6-dihydro-1,4λ⁶-oxathiine-3-carboximidic acid

2-methyl-4,4-dioxo-n-phenyl-5,6-dihydro-1,4λ⁶-oxathiine-3-carboximidic acid

C12H13NO4S (267.0565)


   

(3r,6s,8s)-6,8-dihydroxy-4,9-dioxa-2-azatricyclo[8.4.0.0³,⁸]tetradeca-1(10),11,13-triene-14-carboxylic acid

(3r,6s,8s)-6,8-dihydroxy-4,9-dioxa-2-azatricyclo[8.4.0.0³,⁸]tetradeca-1(10),11,13-triene-14-carboxylic acid

C12H13NO6 (267.0743)


   

(2r)-2-hydroxy-3-(4-hydroxy-2-imino-6-oxo-1,5-dihydropteridin-7-yl)propanoic acid

(2r)-2-hydroxy-3-(4-hydroxy-2-imino-6-oxo-1,5-dihydropteridin-7-yl)propanoic acid

C9H9N5O5 (267.0604)


   

(3r,6s)-6,8-dihydroxy-4,9-dioxa-2-azatricyclo[8.4.0.0³,⁸]tetradeca-1(10),11,13-triene-14-carboxylic acid

(3r,6s)-6,8-dihydroxy-4,9-dioxa-2-azatricyclo[8.4.0.0³,⁸]tetradeca-1(10),11,13-triene-14-carboxylic acid

C12H13NO6 (267.0743)


   

6-(2-carboxyethyl)-8-hydroxy-5-oxo-2,3-dihydro-1h-indolizine-3-carboxylic acid

6-(2-carboxyethyl)-8-hydroxy-5-oxo-2,3-dihydro-1h-indolizine-3-carboxylic acid

C12H13NO6 (267.0743)


   

6,8-dihydroxy-4,9-dioxa-2-azatricyclo[8.4.0.0³,⁸]tetradeca-1(10),11,13-triene-14-carboxylic acid

6,8-dihydroxy-4,9-dioxa-2-azatricyclo[8.4.0.0³,⁸]tetradeca-1(10),11,13-triene-14-carboxylic acid

C12H13NO6 (267.0743)


   

(2r)-2-[(4-hydroxyphenyl)formamido]pentanedioic acid

(2r)-2-[(4-hydroxyphenyl)formamido]pentanedioic acid

C12H13NO6 (267.0743)


   

2-hydroxy-3-(4-hydroxy-2-imino-6-oxo-1,5-dihydropteridin-7-yl)propanoic acid

2-hydroxy-3-(4-hydroxy-2-imino-6-oxo-1,5-dihydropteridin-7-yl)propanoic acid

C9H9N5O5 (267.0604)